Tool
Supplement comparison tool
Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.
Add to comparison (2/4)
| Category | TRT | TRT |
| Evidence strength | Strong evidence | Strong evidence |
| Evidence Score | 5/5 | 5/5 |
| User rating | 4.6 (58) | 4.7 (102) |
| Typical dose | Not applicable in the sense of drug dosing — what matters here is choosing an injection schedule that minimizes peak concentrations (e.g. more frequent, smaller doses instead of infrequent, large ones) as part of managing erythrocytosis risk. | Not applicable — this entry describes a safety protocol, not therapy dosing |
| Form | A blood count assessing hematocrit and hemoglobin — done before starting TRT (baseline value), then periodically throughout therapy. | Monitoring: complete blood count with hematocrit every 3–6 months in the first year, PSA and digital rectal exam before starting and periodically thereafter, lipid panel once a year |
| Average price | — | — |
| Monthly cost | — | — |
| Time to effects | The first measurable rises in hematocrit typically appear after several weeks to a few months of therapy; full stabilization at the new, higher equilibrium value most often occurs between month 3 and month 12 of treatment, absent any intervention. | Not applicable — monitoring is an ongoing process that continues throughout the entire course of therapy. |
| Who it's for | Men starting TRT who want to understand why blood count monitoring is a mandatory part of therapy, not a formality | All patients starting or continuing TRT |